Industry Overview

UK mammography market was valued at $157.4 million in 2025 and is expected to reach $ 429.0 million by 2035, and is growing at a CAGR of 10.6% during the forecast period (2026–2035). The market is experiencing steady expansion, supported by a structured screening framework and continuous advancements in diagnostic imaging technologies. Increasing participation in national breast screening programs has contributed to higher procedure volumes across healthcare facilities. The integration of digital systems and improved imaging accuracy has enhanced early detection rates and clinical outcomes. Additionally, demographic trends, particularly an aging population, are influencing the demand for routine examinations. Public health initiatives and awareness efforts are also encouraging timely screenings. Ongoing investments in healthcare infrastructure further support the consistent development of this sector.

Market Dynamics

Rising Adoption of Digital Breast Imaging Technologies

The transition toward advanced digital imaging systems is shaping the development of the market. Healthcare providers are increasingly integrating digital mammography and tomosynthesis to enhance diagnostic precision. These technologies support improved image clarity and enable better identification of abnormalities at earlier stages. The shift is also supported by efforts to modernize radiology infrastructure across medical facilities. In addition, digital platforms allow efficient storage and sharing of patient data within clinical networks. This trend continues to strengthen diagnostic capabilities and streamline workflow efficiency.

Expansion of Organized Screening and Preventive Care Programs

The growing emphasis on structured screening initiatives is contributing to consistent market demand. National programs are encouraging routine examinations, particularly among high-risk and aging populations. Increased public awareness has led to higher participation rates in preventive healthcare services. Healthcare authorities are also focusing on improving accessibility to screening services across regions. This has resulted in a broader reach of diagnostic services beyond urban centers. The continued prioritization of early detection is reinforcing the importance of regular screening practices.

Market Segmentation

• Based on the product type, the market is segmented into digital systems, analog systems, biopsy systems, film screen systems, and others.
• Based on the end-users, the market is segmented into hospital & clinics and diagnostic centers.

Digital Systems Segment to Lead the Market with the Largest Share

The increasing preference for digitally enabled imaging solutions is influencing segment expansion. These systems offer improved image resolution and faster processing, supporting timely clinical decisions. Market participants such as Siemens Healthineers, GE HealthCare, and Fujifilm are strengthening their portfolios through continuous upgrades and system enhancements. Recent developments indicate a focus on integrating artificial intelligence to assist radiologists in image interpretation. Healthcare facilities are gradually replacing conventional equipment with advanced platforms to improve efficiency. This shift is expected to sustain demand as providers prioritize accuracy and workflow optimization.

Diagnostic Centers: A Key Segment in Market Growth

Independent diagnostic facilities are gaining importance due to their accessibility and specialized service offerings. These centers are expanding their capabilities to manage increasing screening volumes, particularly in urban and semi-urban regions. Key companies are collaborating with diagnostic networks to improve service delivery and patient reach. Recent trends highlight investments in compact and cost-effective imaging solutions suited for standalone facilities. The emphasis on shorter waiting times and patient convenience is also supporting segment growth. As preventive healthcare gains attention, these centers continue to play a significant role in early detection services.

Market Players Outlook

The major companies operating in the UK mammography market include Hologic, Inc., GE HealthCare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., and FUJIFILM Holdings Corp., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Development

• In February 2026, NHS England reported a significant expansion in breast screening activity, with attendance reaching a ten-year high and nearly 1.94 million women screened in 2024 to 2025. This reflects strengthened outreach initiatives, increased invitations, and improved access to mammography services across the UK. The development highlights a clear rise in early cancer detection and indicates continued investment in screening infrastructure and service delivery.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• UK-wise analysis of major geographical regions.
• Key companies operating in the UK mammography market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.